Do analysts recommend INGN or SKYA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to INGN or SKYA?

In the previous week, Inogen had 2 more articles in the media than SkyAI, Inc. Common Stock. MarketBeat recorded 5 mentions for Inogen and 3 mentions for SkyAI, Inc. Common Stock. SkyAI, Inc. Common Stock's average media sentiment score of 0.67 beat Inogen's score of 0.13 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SkyAI, Inc. Common Stock 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PDEX or SKYA?

Pro-Dex currently has a consensus price target of $70.00, suggesting a potential upside of 11.31%. Given Pro-Dex's stronger consensus rating and higher probable upside, equities research analysts clearly believe Pro-Dex is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend CVRX or SKYA?

CVRx presently has a consensus target price of $11.50, suggesting a potential upside of 111.79%. Given CVRx's stronger consensus rating and higher probable upside, research analysts plainly believe CVRx is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, CVRX or SKYA?

CVRx has higher revenue and earnings than SkyAI, Inc. Common Stock. CVRx is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 2.54 -$53.31M -$2.02 N/A SkyAI, Inc. Common Stock $200K 245.46 -$282.50M -$1.63 N/A

Do analysts rate STEX or SKYA?

Biosig Technologies presently has a consensus target price of $8.00, indicating a potential upside of 771.84%. Given Biosig Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Biosig Technologies is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biosig Technologies 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is STEX or SKYA more profitable?

SkyAI, Inc. Common Stock's return on equity of -157.91% beat Biosig Technologies' return on equity. Company Net Margins Return on Equity Return on Assets Biosig Technologies N/A -717.92% -336.75% SkyAI, Inc. Common Stock N/A -157.91% -154.40%

Does the media prefer STEX or SKYA?

In the previous week, Biosig Technologies and Biosig Technologies both had 3 articles in the media. Biosig Technologies' average media sentiment score of 0.97 beat SkyAI, Inc. Common Stock's score of 0.67 indicating that Biosig Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biosig Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SkyAI, Inc. Common Stock 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate SKYA or HYPR?

Hyperfine has a consensus price target of $1.78, indicating a potential upside of 63.61%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts clearly believe Hyperfine is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hyperfine 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33

SkyAI, Inc. Common Stock (SKYA) Competitors

$1.16 -0.02 (-1.69%)

As of 07/10/2026 04:00 PM Eastern

Compare

SKYA vs. INGN, PDEX, CVRX, STEX, and HYPR

Should you buy SkyAI, Inc. Common Stock stock or one of its competitors? MarketBeat compares SkyAI, Inc. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SkyAI, Inc. Common Stock include Inogen (INGN), Pro-Dex (PDEX), CVRx (CVRX), Biosig Technologies (STEX), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.

How does SkyAI, Inc. Common Stock compare to Inogen?

Inogen (NASDAQ:INGN) and SkyAI, Inc. Common Stock (NASDAQ:SKYA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

89.9% of Inogen shares are held by institutional investors. Comparatively, 17.2% of SkyAI, Inc. Common Stock shares are held by institutional investors. 2.5% of Inogen shares are held by insiders. Comparatively, 20.0% of SkyAI, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Inogen has a beta of 1.58, indicating that its stock price is 58% more volatile than the broader market. Comparatively, SkyAI, Inc. Common Stock has a beta of 2.1, indicating that its stock price is 110% more volatile than the broader market.

Inogen has higher revenue and earnings than SkyAI, Inc. Common Stock. Inogen is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$351.50M	0.50	-$22.75M	-$0.91	N/A
SkyAI, Inc. Common Stock	$200K	245.46	-$282.50M	-$1.63	N/A

In the previous week, Inogen had 2 more articles in the media than SkyAI, Inc. Common Stock. MarketBeat recorded 5 mentions for Inogen and 3 mentions for SkyAI, Inc. Common Stock. SkyAI, Inc. Common Stock's average media sentiment score of 0.67 beat Inogen's score of 0.13 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SkyAI, Inc. Common Stock	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to Inogen's net margin of -7.08%. Inogen's return on equity of -12.90% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-7.08%	-12.90%	-8.27%
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Inogen beats SkyAI, Inc. Common Stock on 9 of the 15 factors compared between the two stocks.

How does SkyAI, Inc. Common Stock compare to Pro-Dex?

Pro-Dex (NASDAQ:PDEX) and SkyAI, Inc. Common Stock (NASDAQ:SKYA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Pro-Dex has a net margin of 16.08% compared to SkyAI, Inc. Common Stock's net margin of 0.00%. Pro-Dex's return on equity of 22.78% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	16.08%	22.78%	14.30%
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%

Pro-Dex currently has a consensus price target of $70.00, suggesting a potential upside of 11.31%. Given Pro-Dex's stronger consensus rating and higher probable upside, equities research analysts clearly believe Pro-Dex is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Pro-Dex has higher revenue and earnings than SkyAI, Inc. Common Stock. SkyAI, Inc. Common Stock is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$66.59M	3.01	$8.98M	$3.62	17.37
SkyAI, Inc. Common Stock	$200K	245.46	-$282.50M	-$1.63	N/A

In the previous week, SkyAI, Inc. Common Stock had 2 more articles in the media than Pro-Dex. MarketBeat recorded 3 mentions for SkyAI, Inc. Common Stock and 1 mentions for Pro-Dex. SkyAI, Inc. Common Stock's average media sentiment score of 0.67 beat Pro-Dex's score of 0.00 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the news media.

Company	Overall Sentiment
Pro-Dex	Neutral
SkyAI, Inc. Common Stock	Positive

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 17.2% of SkyAI, Inc. Common Stock shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by insiders. Comparatively, 20.0% of SkyAI, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Pro-Dex has a beta of 0.01, meaning that its stock price is 99% less volatile than the broader market. Comparatively, SkyAI, Inc. Common Stock has a beta of 2.1, meaning that its stock price is 110% more volatile than the broader market.

Summary

Pro-Dex beats SkyAI, Inc. Common Stock on 11 of the 16 factors compared between the two stocks.

How does SkyAI, Inc. Common Stock compare to CVRx?

CVRx (NASDAQ:CVRX) and SkyAI, Inc. Common Stock (NASDAQ:SKYA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

CVRx has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, SkyAI, Inc. Common Stock has a beta of 2.1, meaning that its stock price is 110% more volatile than the broader market.

75.3% of CVRx shares are owned by institutional investors. Comparatively, 17.2% of SkyAI, Inc. Common Stock shares are owned by institutional investors. 13.9% of CVRx shares are owned by company insiders. Comparatively, 20.0% of SkyAI, Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

CVRx presently has a consensus target price of $11.50, suggesting a potential upside of 111.79%. Given CVRx's stronger consensus rating and higher probable upside, research analysts plainly believe CVRx is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%

CVRx has higher revenue and earnings than SkyAI, Inc. Common Stock. CVRx is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	2.54	-$53.31M	-$2.02	N/A
SkyAI, Inc. Common Stock	$200K	245.46	-$282.50M	-$1.63	N/A

In the previous week, SkyAI, Inc. Common Stock had 2 more articles in the media than CVRx. MarketBeat recorded 3 mentions for SkyAI, Inc. Common Stock and 1 mentions for CVRx. SkyAI, Inc. Common Stock's average media sentiment score of 0.67 beat CVRx's score of 0.00 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the news media.

Company	Overall Sentiment
CVRx	Neutral
SkyAI, Inc. Common Stock	Positive

Summary

CVRx beats SkyAI, Inc. Common Stock on 9 of the 17 factors compared between the two stocks.

How does SkyAI, Inc. Common Stock compare to Biosig Technologies?

Biosig Technologies (NASDAQ:STEX) and SkyAI, Inc. Common Stock (NASDAQ:SKYA) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

Biosig Technologies has a beta of 1.94, indicating that its stock price is 94% more volatile than the broader market. Comparatively, SkyAI, Inc. Common Stock has a beta of 2.1, indicating that its stock price is 110% more volatile than the broader market.

SkyAI, Inc. Common Stock's return on equity of -157.91% beat Biosig Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biosig Technologies	N/A	-717.92%	-336.75%
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%

SkyAI, Inc. Common Stock has higher revenue and earnings than Biosig Technologies. SkyAI, Inc. Common Stock is trading at a lower price-to-earnings ratio than Biosig Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biosig Technologies	$40K	4,170.49	-$462.77M	-$9.71	N/A
SkyAI, Inc. Common Stock	$200K	245.46	-$282.50M	-$1.63	N/A

In the previous week, Biosig Technologies and Biosig Technologies both had 3 articles in the media. Biosig Technologies' average media sentiment score of 0.97 beat SkyAI, Inc. Common Stock's score of 0.67 indicating that Biosig Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biosig Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SkyAI, Inc. Common Stock	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Biosig Technologies presently has a consensus target price of $8.00, indicating a potential upside of 771.84%. Given Biosig Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Biosig Technologies is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biosig Technologies	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

7.2% of Biosig Technologies shares are held by institutional investors. Comparatively, 17.2% of SkyAI, Inc. Common Stock shares are held by institutional investors. 52.7% of Biosig Technologies shares are held by company insiders. Comparatively, 20.0% of SkyAI, Inc. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Biosig Technologies and SkyAI, Inc. Common Stock tied by winning 7 of the 14 factors compared between the two stocks.

How does SkyAI, Inc. Common Stock compare to Hyperfine?

SkyAI, Inc. Common Stock (NASDAQ:SKYA) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to Hyperfine's net margin of -226.88%. Hyperfine's return on equity of -98.83% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%
Hyperfine	-226.88%	-98.83%	-67.09%

Hyperfine has higher revenue and earnings than SkyAI, Inc. Common Stock. Hyperfine is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SkyAI, Inc. Common Stock	$200K	245.46	-$282.50M	-$1.63	N/A
Hyperfine	$11.40M	9.49	-$35.57M	-$0.41	N/A

17.2% of SkyAI, Inc. Common Stock shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 20.0% of SkyAI, Inc. Common Stock shares are held by company insiders. Comparatively, 26.3% of Hyperfine shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Hyperfine has a consensus price target of $1.78, indicating a potential upside of 63.61%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts clearly believe Hyperfine is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hyperfine	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, SkyAI, Inc. Common Stock had 1 more articles in the media than Hyperfine. MarketBeat recorded 3 mentions for SkyAI, Inc. Common Stock and 2 mentions for Hyperfine. SkyAI, Inc. Common Stock's average media sentiment score of 0.67 beat Hyperfine's score of 0.00 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the media.

Company	Overall Sentiment
SkyAI, Inc. Common Stock	Positive
Hyperfine	Neutral

SkyAI, Inc. Common Stock has a beta of 2.1, meaning that its share price is 110% more volatile than the broader market. Comparatively, Hyperfine has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

Summary

Hyperfine beats SkyAI, Inc. Common Stock on 9 of the 16 factors compared between the two stocks.

Get SkyAI, Inc. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SKYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SKYA vs. The Competition

Export

Metric	SkyAI, Inc. Common Stock	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$49.94M	$8.80B	$7.12B	$12.61B
Dividend Yield	N/A	2.52%	2.68%	7.83%
P/E Ratio	-0.71	16.12	27.19	24.56
Price / Sales	245.46	7.15	590.19	121.71
Price / Cash	N/A	18.15	49.34	60.04
Price / Book	0.13	3.60	10.90	6.39
Net Income	-$282.50M	$228.19M	$3.57B	$331.44M
7 Day Performance	-5.69%	-0.18%	-0.25%	0.37%
1 Month Performance	2.65%	-1.17%	4.53%	0.54%
1 Year Performance	-79.76%	-2.53%	29.18%	21.93%

SkyAI, Inc. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SKYA SkyAI, Inc. Common Stock	1.3299 of 5 stars	$1.16 -1.7%	N/A	-80.2%	$49.94M	$200K	N/A	55	News Coverage Short Interest Decrease Gap Up
INGN Inogen	1.7025 of 5 stars	$6.45 -6.9%	N/A	-10.5%	$187.63M	$348.67M	N/A	1,030	News Coverage
PDEX Pro-Dex	2.351 of 5 stars	$58.55 +0.3%	$70.00 +19.6%	+31.7%	$186.44M	$66.59M	16.17	140
CVRX CVRx	1.851 of 5 stars	$5.14 -13.5%	$11.50 +123.7%	-22.0%	$157.62M	$56.65M	N/A	160
STEX Biosig Technologies	2.607 of 5 stars	$0.85 +6.0%	$8.00 +840.8%	N/A	$145.90M	$40K	N/A	50	Buyback Announcement

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SKYA) was last updated on 7/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SkyAI, Inc. Common Stock (SKYA) Competitors

SKYA vs. INGN, PDEX, CVRX, STEX, and HYPR

How does SkyAI, Inc. Common Stock compare to Inogen?

Summary

How does SkyAI, Inc. Common Stock compare to Pro-Dex?

Summary

How does SkyAI, Inc. Common Stock compare to CVRx?

Summary

How does SkyAI, Inc. Common Stock compare to Biosig Technologies?

Summary

How does SkyAI, Inc. Common Stock compare to Hyperfine?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKYA vs. The Competition

SkyAI, Inc. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SkyAI, Inc. Common Stock (SKYA) Competitors

SKYA vs. INGN, PDEX, CVRX, STEX, and HYPR

How does SkyAI, Inc. Common Stock compare to Inogen?

Do insiders and institutionals hold more shares of INGN or SKYA?

Which has more volatility & risk, INGN or SKYA?

Which has higher earnings & valuation, INGN or SKYA?

Does the media refer more to INGN or SKYA?

Is INGN or SKYA more profitable?

Do analysts recommend INGN or SKYA?

Summary

How does SkyAI, Inc. Common Stock compare to Pro-Dex?

Is PDEX or SKYA more profitable?

Do analysts recommend PDEX or SKYA?

Which has better earnings & valuation, PDEX or SKYA?

Does the media prefer PDEX or SKYA?

Do insiders & institutionals hold more shares of PDEX or SKYA?

Which has more volatility and risk, PDEX or SKYA?

Summary

How does SkyAI, Inc. Common Stock compare to CVRx?

Which has more risk & volatility, CVRX or SKYA?

Do institutionals and insiders hold more shares of CVRX or SKYA?

Do analysts recommend CVRX or SKYA?

Is CVRX or SKYA more profitable?

Which has higher earnings and valuation, CVRX or SKYA?

Does the media favor CVRX or SKYA?

Summary

How does SkyAI, Inc. Common Stock compare to Biosig Technologies?

Which has more volatility & risk, STEX or SKYA?

Is STEX or SKYA more profitable?

Which has preferable valuation and earnings, STEX or SKYA?

Does the media prefer STEX or SKYA?

Do analysts rate STEX or SKYA?

Do insiders & institutionals believe in STEX or SKYA?

Summary

How does SkyAI, Inc. Common Stock compare to Hyperfine?

Is SKYA or HYPR more profitable?

Which has higher valuation and earnings, SKYA or HYPR?

Do insiders and institutionals hold more shares of SKYA or HYPR?

Do analysts rate SKYA or HYPR?

Does the media refer more to SKYA or HYPR?

Which has more risk and volatility, SKYA or HYPR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKYA vs. The Competition

SkyAI, Inc. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools